Dement Neurocogn Disord.  2013 Sep;12(3):72-77. 10.12779/dnd.2013.12.3.72.

Can Silent Ischemic Cerebral Lesions Affect Cognition of Parkinson's Disease Dementia?

• Kang IU
• Song IU
• Lee SJ
• Kim YD
• Cho HJ
• Chung SW
• Yang Y

• KMID: 1488583
• DOI: http://doi.org/10.12779/dnd.2013.12.3.72

Abstract

BACKGROUND
Several studies have shown that the presence of cerebrovascular lesions may play an important role for determining the severity of the clinical symptoms of dementia. But no study to date has explored the clinical effect of cerebrovascular disease in Parkinson's disease with dementia (PDD), although cerebrovascular disease is common causes of dementia in elderly population. Therefore we conducted this study to evaluate the relationship between silent cerebrovascular lesions and cognitive decline in PDD.
METHODS
Only 27 patients with PDD were chosen; 17 patients had PDD with silent cerebral ischemic lesions (PDDI) and 10 patients had PDD without silent cerebral ischemic lesions (pure PDD). These subjects received the global cognitive function testing and were all evaluated with detailed neuropsychological tests including attention, memory, language, and also the visuospatial and frontal function.
RESULTS
There were no significant differences between pure PDD and PDDI group on general cognitive functions tests. Regard to mean time duration of suffering from Parkinson motor symptoms and motor function scale, pure PDD group showed more long duration than PDDI group but there was no significant difference between two groups. Furthermore, there were not any significant differences between the two groups on detailed neuropsychological tests.
CONCLUSIONS
We concluded that silent cerebrovascular lesions do not contribute to neuropsychological severity of PDD, although vascular disease is a common cause of cognitive impairment in the elderly. Thus the results of the present study suggest that factors other than cerebrovascular disease contribute to severity of PDD.

Keyword

Cerebrovascular lesions; Parkinson's disease; Dementia

MeSH Terms

Aged
Cognition
Dementia
Humans
Memory
Neuropsychological Tests
Parkinson Disease
Stress, Psychological
Vascular Diseases

Reference

1. Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, et al. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol. 1992; 49:492–497.

2. Jellinger KA. Prevalence of Alzheimer lesions in Parkinson's disease. Mov Disord. 2003; 18:1207–1208.

3. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sørensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology. 2001; 56:730–736.

4. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003; 348:1215–1222.

5. Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol. 2000; 57:1474–1479.

6. Jellinger KA, Mitter-Ferstl E. The impact of cerebrovascular lesions in Alzheimer disease--a comparative autopsy study. J Neurol. 2003; 250:1050–1055.

7. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55:181–184.

8. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007; 22:1689–1707.

9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. ed 4. Washington: American Psychiatric Association;1994. p. 143–147.

10. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005; 65:1863–1872.

11. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000; 59:23–30.

12. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology. 1993; 43:250–260.

13. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998; 121:2249–2257.

14. Kang Y, Na DL, Hahn SH. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997; 15:300–308.

15. Choi SH, Na DL, Lee BH, Hahm DS, Jeong JH, Yoon SJ, et al. Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale. J Korean Neurol Assoc. 2001; 19:585–591.

16. Kang YW. Samsung neuropsychological screening battery. In : Kang YW, editor. Current Research in Dementia. Seoul: The Korean Dementia Association;1998. p. 99–107.

17. Kim H, Na DL. Korean-Boston Naming Test. Seoul: Hakji Co;1997.

18. Kim H, Kim EY, Na DL. Naming deficits in patients with dementia of the Alzheimer type: error analysis of the Korean version of the Boston Naming Test. J Korean Neurol Assoc. 1997; 15:1012–1021.

19. Song IU, Kim JS, Kim YI, Eah KY, Lee KS. Clinical significance of silent cerebral infarctions in patients with Alzheimer disease. Cogn Behav Neurol. 2007; 20:93–98.

20. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003; 2:89–98.

21. Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology. 2005; 64:494–500.

22. De Ronchi D, Palmer K, Pioggiosi P, Atti AR, Berardi D, Ferrari B, et al. The combined effect of age, education, and stroke on dementia and cognitive impairment no dementia in the elderly. Dement Geriatr Cogn Disord. 2007; 24:266–273.

23. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, et al. Dementia after stroke: the Framingham Study. Stroke. 2004; 35:1264–1268.

24. Salganik I, Korczyn A. Risk factors for dementia in Parkinson's disease. Adv Neurol. 1990; 53:343–347.

25. Haugarvoll K, Aarsland D, Wentzel-Larsen T, Larsen JP. The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease. Acta Neurol Scand. 2005; 112:386–390.

26. Papapetropoulos S, Gonzalez J, Mash DC. The effect of ischemic cerebrovascular disease on the clinical characteristics of Parkinson's disease. A post-mortem study. Eur J Neurol. 2006; 13:96–97.

27. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2003; 2:229–237.

28. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 2000; 54:1916–1921.

29. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol. 2002; 59:102–112.

30. Jellinger KA. General aspects of neurodegeneration. J Neural Transm Suppl. 2003; 101–144.